• 2004

Company Description

ProMIS Neurosciences develops therapeutic products and diagnostic devices targeting misfolded protein diseases.

ProMIS Neurosciences is a development stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment of neurodegenerative diseases, in particular Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS).